Early Molecular Response with Generic Imatinib Therapy in Sokal/Hasford Intermediate- & High-Risk Chronic Phase Chronic Myeloid Leukemia Patients: A Single Institution Experience from India
- Resource Type
- Abstract
- Source
- In
Blood 29 November 2018 132 Supplement 1:4276-4276 - Subject
- Language
- ISSN
- 0006-4971